Vaccination in pregnancy against pertussis: a consensus statement on behalf of the global pertussis initiative
Highlights-Vaccination against pertussis in pregnancy is safe for pregnant women and
newborns.-Vaccination against pertussis during the second or early third trimester of …
newborns.-Vaccination against pertussis during the second or early third trimester of …
Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other …
AR Andersen, SK Kolmos, KL Flanagan, CS Benn - Vaccine, 2022 - Elsevier
Background Several countries have introduced maternal immunisation with pertussis
vaccine to provide protection against pertussis in early infancy. There is increasing interest …
vaccine to provide protection against pertussis in early infancy. There is increasing interest …
[HTML][HTML] A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of …
K Chokephaibulkit, T Puthanakit, N Bhat, S Mansouri… - Vaccine, 2022 - Elsevier
Background A phase 2 randomized-controlled safety and immunogenicity trial evaluating
different doses of recombinant acellular pertussis vaccine containing genetically-inactivated …
different doses of recombinant acellular pertussis vaccine containing genetically-inactivated …
[HTML][HTML] Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus …
L Fortuna, S Chaithongwongwatthana… - Vaccine, 2020 - Elsevier
A new generation of recombinant acellular pertussis vaccine containing genetically
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …
[HTML][HTML] A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant …
T Puthanakit, K Chokephaibulkit… - Vaccine, 2023 - Elsevier
Introduction Despite a decrease in infections caused by Bordetella pertussis due to COVID-
19 pandemic, booster vaccination of pregnant women is still recommended to protect …
19 pandemic, booster vaccination of pregnant women is still recommended to protect …
[HTML][HTML] Pertussis in Lao PDR: seroprevalence and disease
D Kleine, S Billamay, P Chanthavilay… - International Journal of …, 2020 - Elsevier
Objectives Pertussis is a debilitating vaccine-preventable infection. The aim of this study was
to determine susceptibility and exposure to pertussis in Lao PDR in different age groups and …
to determine susceptibility and exposure to pertussis in Lao PDR in different age groups and …
Противококлюшные антитела классов IgМ, IgG и IgA у беременных в I–II–III триместрах
ТА Скирда, ОЮ Борисова, НТ Гадуа… - Журнал …, 2021 - journal.niidi.ru
ПРОТИВОКОКЛЮШНЫЕ АНТИТЕЛА КЛАССОВ IgМ, Igg И IgA У БЕРЕМЕННЫХ В I–II–III
ТРИ Page 1 Оригинальное исследование Том 13, №3, 2021 ЖУРНАЛ ИНФЕКТОЛОГИИ …
ТРИ Page 1 Оригинальное исследование Том 13, №3, 2021 ЖУРНАЛ ИНФЕКТОЛОГИИ …
[PDF][PDF] Seroprevalence of Bordetella pertussis antibodies among a group of young adults
A Skiba, S Raman, I Rzucidlo, D Sereda… - Journal of Pre …, 2021 - bibliotekanauki.pl
Introduction. Bordetella pertussis is a Gram-negative rod which attacks the respiratory
system and causes whooping cough disease. Despite the high percentage of childhood …
system and causes whooping cough disease. Despite the high percentage of childhood …
[引用][C] Hacettepe Üniversitesi Hastanesi'ne Doğum İçin Yatan Kadınlarda ve Kordon Kanında Boğmaca Antikor Düzeylerinin Değerlendirilmesi
HE Erik - 2021 - avesis.hacettepe.edu.tr